Treatment
Psychiatry
Psychogeriatric
Diagnosis
מומחה לפסיכיאטריה
ופיסכוגריאטריה
מנהל מחלקה פסיכוגריאטרית
בבית חולים "לב -השרון" פרדסיה
טלפון: 052-3020354
Specialized in psychiatry and
psychogeriatric
Head Of Psychogeriatric
Departement
Tel: +972-52-3020354
Dr. B.Finkel M.D
ד"ר פינקל ב.

פרקים נבחרים מעבודות מדעיות של ד"ר פינקל ב.
ד"ר פינקל מומחה בפסיכיאטריה ופסיכוגריאטריה,כאן נציג חלק מהעבודות המדעיות על ידע מעמיק בתחומים שונים.
"פכסיכוגריאטריה-פרקים נבחרים",הוא ספר לימוד מקצועי ומקיף,הראשון
שרואה אור בשפה העברית,והוא פורס לפני הקורא את כל התחום הנרחב
של מחלות אורגניות ומחלות נפש,הפוגעות בתפקוד המוחי של הקשיש.
כל הנושאים העיקריים של תחום הפסיכוגריאטריה נכללים בספר,מהנפש אל הגוף,מדיכאון,דרך דליריום
ועד לדמנציה.
בספר זה ד"ר פינקל בוריס כתב פרק חשוב: תסמינים התנהגותיים ונפשיים בדמנציה (פרק 10,עמוד269)

Published :
1. Genotypic Association between the Dopamine D3 Receptor and Tardive Dyskinesia in Chronic Schizophrenia
Molecular Psychiatry 4:247-253, 1999
Dr.Finkel B.:
2. Olanzapine treatment in patients with typical and atypical neuroleptic associated agranulocytosis.
International Clinical Psychopharmacology 13: 133-135, 1998
Dr.Finkel B.:
3. Hallucination Persisting Perception disorder Treatment with Clonidine.
American Journal of Psychiatry 155: 1460, 1998
Dr.Finkel B.:
4. Risperidone associated agranulocytosis.
American Journal of Psychiatry 155: 855-856, 1998
Dr.Finkel.B.:
5. A rare short allele of serotonin transporter region (5-HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan origin.
Psychiatric Genetic 10: 1-5, 2000
Dr.Finkel.B.:
6. Dose dependent olanzapine-associated leukopenia: three case reports
International Clinical Psychopharmacology , 16: 117-119, 2001 *
Dr.Finkel.B.:
7. Intermittent luteal phase nefazodone treatment of premenstrual dysphoric disorder
Journal of Psychopharmacology , 15: 58-60, 2001 *
Dr.Finkel.B.
:
8. LSD-induced hallucinogen persisting perception disorder treatment with
clonidine: an open pilot study
International Clinical Psychopharmacology, 18: 35-37, 2000 *
Dr.Finkel.B
9. Angiotensin Converting Enzyme Gene Insertion Deletion Polymorphism: Case Control Association Studies in Schizophrenia, Major Affective Disorder and Tardive Dyskinesia and a Family Based Association Study in Schizophrenia.
American Journal of Medical Genetics (Neuropsychiatric Genetics)- September, 2001
Dr.Finkel.B.:
10. Association between the serotonin 2A receptor gene and tardive dyskinesia in
chronic schizophrenia.
Molecular Psychiatry (in press) *
Dr.Finkel.B.:
11. Association between the serotonin 2C receptor gene and tardive dyskinesia in
chronic schizophrenia; additive contribution of 5-HT2Cser and DRD3gly alleles to
susceptibility.
Psychopharmacology (in press) *
Dr.Funkel.B.:
12. Flashback and hallucinogen persisting perception disorder: clinical aspects and
pharmacological treatment approach
Israel Journal of Psychiatry (in press) *
Dr.Finkel.B.:
13. Buspirone in the treatment of adjustment disorder
International Clinical Psychopharmacology
Dr.Finkel.B.:
14. Olanzapine overdose. Complication and Management
International Clinical Psychopharmacology
15. Video Testimony of Long-Term Hospitalized
Psychiatrically III Holocaust Survivors
Am J Psychiatry 162;12, December 2005
Dr.Finkel.B.:
16. היפול בתרופות במחלת הסכיזופרניה: השווה בין התרופות מהדור השני
((הרפואה כרך 144, חב' ד' (אפריל 2005)
Dr.Finkel.B.:
ABSTRACTS.
1. Olanzapine treatment in patients with typical and atypical neuroleptic-associated
Agranulocytosis.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
KfarGiladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1,1998
Dr.Finkel B.,//
2. Dopamine Transporter polymorphism and tardive dysknesia in chronic
schizophrenia patients: an association study.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
KfarGiladi, Israel.
Israel Journal of Psychiatry (Supplement). Vol. 35, Number 1, 1998
Dr.Finkel B.,//
3. Dose dependent olanzapine-associated leukopenia: three case reports.
The Sixth Annual Meeting of the Israeli Association of Biological Psychiatry. March 2001.
Kfar Giladi, Israel.
Dr.Finkel.B.,//
4. LSD-induced poor insight flashback and long term treatment with risperidone.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement). Vol. 36, Number 1, 1999
Dr.Finkel.B.,//
5. LSD-induced intoxication treatment with risperidone.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi,Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999
Dr.Finkel.B.,//
6. LSD-induced anxiety disorder treatment with buspirone.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998. Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement). Vol. 35, Number 1, 1998
Dr.Finkel.B.,//
7. Intermittent, luteal phase nefazodone treatment of premenstrual disphoric disorder.
The Sixth Annual Meeting of the Israeli Association of Biological Psychiatry. March 2001.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 38, Number 1, 2001
Dr.Finkel.B.,//
8. Concomitant hallucinogen persisting disorder (HPPD) and major depressive
disorder: management with nefazodone.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement). Vol. 36, Number 1, 1999
Dr.Finkel.B.,//
9. Risperidone in Tourette's disorder with OCD.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999
Dr.Finkel.B.,//
10. Association between the Dopamine D3 Receptor and Tardive Dyskinesia in
Schizophrenia.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999
Dr.Finkel.B.,//
11. Psychosis associated with clomiphene treatment.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement). Vol. 35, Number 1, 1998
Dr.Finkel.,//
12. LSD-induced psychotic disorder treatment with risperidone and Hallucinogen
Persisting Perception Disorder.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement). Vol. 35, Number 1, 1998
Dr.Finkel.,//
PAPERS PRESENTED AT SCIENTIFIC MEETINGS.
1. Intermittent, luteal phase nefazodone treatment of premenstrual disphoric disorder.
The Sixth Annual Meeting of the Israeli Association of Biological
Psychiatry. March 2001. Kfar Giladi. Israel
Dr.Finkel.B.,//
2. Dose dependent olanzapine-associated leukopenia: three case reports
The Sixth Annual Meeting of the Israeli Association
Dr.Finkel.B.,//
3. Concomitant hallucinogen persisting disorder (HPPD) and major depressive disorder: management with nefazodone.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999.
Dr.Finkel.B.,//
4. Risperidone in Tourette ‘disorder with OCD.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999.
Dr.Finkel.B.,//
5. LSD-induced poor insight flashback and long term treatment with risperidone.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999.
Dr.Finkel.B.,//
6. LSD-induced intoxication treatment with risperidone.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999.
Dr.Finkel.B.,//
7. Association between the Dopamine D3 Receptor and Tardive Dyskinesia in Schizophrenia.
The Fifth Congress of the Israeli Association of Biological Psychiatry. March 1999.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 36, Number 1, 1999.
Dr.Finkel.B.,//
8. Psychosis associated with clomiphene treatment.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1, 1998.
Dr.Finkel.B.,//
9. LSD-induced anxiety disorder treatment with buspirone.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1, 1998.
Dr.Finkel.B.,//
10. LSD-induced psychotic disorder treatment with risperidone and Hallucinogen Persisting
Perception Disorder.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1, 1998.
Dr.Finkel.B.,
11. LSD-induced Hallucinogen Persistent Perception Disorder treatment with clonidine:
a pilo open study.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1, 1998.
Dr.Finkel.B.,//
12. Olanzapine treatment Lerner AG,in patients with typical and atypical
neuroleptic-associated. Agranulocytosis.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1, 1998.
Dr.Finkel.B.,//
13. Dopamine Transporter polymorphism and tardive dysknesia in chronic shizophrenia patients: an association study.
The Fourth Congress of the Israeli Association of Biological Psychiatry. March 1998.
Kfar Giladi, Israel.
Israel Journal of Psychiatry (Supplement), Vol. 35, Number 1, 1998
Dr.Finkel.B.,//
14. Naltrexone induced tobacco intake reduction.
Third Congress of the Israeli Association of Biological Psychiatry.March 1996.
Kfar Giladi, Israel.
Dr.Finkel.B.,//
15. Indicators of good prog G,nosis in naltrexone treatment: a five years prospective study.
The Third Congress of the Israeli Association of Biological Psychiatry. March 1996.
Kfar Giladi, Israel.
Dr.Finkel.B.,//

